FENC
insider transactionsFENNEC PHARMACEUTICALS INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-9.7K
0 buy · 9.7K sell
Net value · 30d
-$93.8K
$0 in · $93.8K out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
1
0 buy · 9.7K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$217.5K
25.0K sh · $8.70
Own +11%
-
Grant·A
Director
$174.0K
20.0K sh · $8.70
Own +11%
-
Grant·A
Director
$174.0K
20.0K sh · $8.70
Own +14%
-
Grant·A
Director
$174.0K
20.0K sh · $8.70
Own +9%
-
Exercise·M
Director · 10b5-1
$38.2K
15.6K sh · $2.45
Own +1%
-
Sell·S
Director · 10b5-1
$93.8K
9.7K sh · $9.62
Own -7%
-
Exercise·M
Director · 10b5-1
$38.2K
15.6K sh · $2.45
Own +13%
-
Grant·A
Chief Medical Officer
$0
168 sh
Own +1%
-
Grant·A
Chief Executive Officer
$0
1.2K sh
Own +2%
-
Grant·A
Chief Commercial Officer
$0
168 sh
Own +1%
-
Grant·A
Chief Strategy Officer
$0
156 sh
Own +1%
-
Grant·A
Robert Andrade KEY
CHIEF FINANCIAL OFFICER
$0
1.7K sh
Own +1%
-
Grant·A
Director · 10b5-1
$0
2.8K sh
Own +2%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | Khalid Islam | Grant A | 25.0K | $217.5K |
| Jun 10, 2026 | Chris A Rallis | Grant A | 20.0K | $174.0K |
| Jun 10, 2026 | Jodi A Cook | Grant A | 20.0K | $174.0K |
| Jun 10, 2026 | Marco Maria Brughera | Grant A | 20.0K | $174.0K |
| Jun 1, 2026 | Rosty Raykov 10b5-1 | Exercise M | 15.6K | $38.2K |
| Jun 1, 2026 | Rosty Raykov 10b5-1 | Sell S | 9.7K | $93.8K |
| Jun 1, 2026 | Rosty Raykov 10b5-1 | Exercise M | 15.6K | $38.2K |
| May 31, 2026 | Pierre Sargis Sayad | Grant A | 168 | $0 |
| May 31, 2026 | Jeffrey S. Hackman KEY | Grant A | 1.2K | $0 |
| May 31, 2026 | Terry L Evans | Grant A | 168 | $0 |
| May 31, 2026 | Christiana Marie Cioffi | Grant A | 156 | $0 |
| May 31, 2026 | Robert Andrade KEY | Grant A | 1.7K | $0 |
| May 31, 2026 | Rosty Raykov 10b5-1 | Grant A | 2.8K | $0 |
About FENC insider trading
This page tracks insider transactions for FENNEC PHARMACEUTICALS INC. (FENC) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.